Literature DB >> 8324743

Penetration of mitomycin C in human bladder.

M G Wientjes1, R A Badalament, R C Wang, F Hassan, J L Au.   

Abstract

The penetration of mitomycin C (MMC) in bladder tissue was studied in patients who received intravesical chemotherapy at the time of radical cystectomy. An intravesical dose of MMC (20 mg/40 ml) was instilled and maintained in the bladder for 60 to 120 min at which time the solution was drained. Within 10 to 60 min after draining the drug solution, the bladder vasculature was ligated, and the bladder was removed. Tissues were sectioned serially in layers parallel to the urothelium and analyzed for MMC concentration. Of the 24 patients evaluated, 17 patients had a low final MMC concentration in urine (< 66 micrograms/ml) or had the MMC solution drained more than 30 min before ligation of the blood vessels. Among these 17 patients, the concentration in the urothelium was measurable in only 4 patients, while the concentrations in deeper tissues were not measurable. In the remaining 7 patients where the urine concentration was > 120 micrograms/ml and where the vasculature was ligated within 30 min after the MMC solution was drained, the bladder wall contained significant MMC concentrations. The drug penetration was studied in the latter 7 patients, using sections of bladder wall that were grossly normal and non-tumor bearing. Concentrations in the bladder wall declined semilogarithmically with tissue depth from the urothelium to the deep muscle and reached a plateau at about 2000 microns depth. The median MMC concentrations were 5.6 micrograms/g in the urothelium and lamina propria interface, 2.7 micrograms/g in the lamina propria, and 0.9 microgram/g in the muscularis. The distance over which the MMC concentration decreased by one-half was about 500 microns. The concentration ratio between the urine and urothelium/lamina propria interface was about 35-fold. The mean plasma concentrations were 0.003, 0.1, and 0.4% of the mean concentration in urine, urothelium, and the averaged bladder tissue concentrations, respectively. Paired superficial tumor and normal tissues were obtained from 5 bladders. In 4 of 5 cases, the concentration in tumors was higher than in normal tissues, while the reverse was seen in the remaining tumor. In one sessile bladder tumor a complete concentration-depth profile could be obtained. While the concentrations in the tumor tissue were 2-3-fold higher than that in the adjacent normal tissue, the rate of concentration declined with respect to tissue depth and hence the distance over which the MMC concentration decreased by one-half was similar in both tumors.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324743

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment.

Authors:  Sung Hyun Kang; Russ Chess-Williams; Shailendra Anoopkumar-Dukie; Catherine McDermott
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-03       Impact factor: 3.000

Review 2.  Intravesical drug delivery. Pharmacokinetic and clinical considerations.

Authors:  M S Highley; A T van Oosterom; R A Maes; E A De Bruijn
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 3.  Adjuvant methods to improve results of local bladder irrigations by chemotherapy for NMIBC.

Authors:  Yuval Freifeld; Yoram Dekel; Avi Stein
Journal:  Curr Urol Rep       Date:  2013-04       Impact factor: 3.092

Review 4.  Alternative therapies in patients with non-muscle invasive bladder cancer.

Authors:  Öner Şanlı; Yair Lotan
Journal:  Turk J Urol       Date:  2017-12-01

5.  Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells.

Authors:  Jasna Lojk; Vladimir Boštjan Bregar; Klemen Strojan; Samo Hudoklin; Peter Veranič; Mojca Pavlin; Mateja Erdani Kreft
Journal:  Histochem Cell Biol       Date:  2017-08-18       Impact factor: 4.304

6.  Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.

Authors:  R Paroni; A Salonia; A Lev; L F Da Pozzo; G Cighetti; F Montorsi; P Rigatti; R Colombo
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

7.  Updates in intravesical electromotive drug administration of mitomycin-C for non-muscle invasive bladder cancer.

Authors:  Savino Mauro Di Stasi; Claus Riedl
Journal:  World J Urol       Date:  2009-02-21       Impact factor: 4.226

8.  Celiac disease and lymphoma risk: a multicentric case--control study in Spain.

Authors:  Carme Farré; Eva Domingo-Domenech; Rebeca Font; Teresa Marques; Alberto Fernandez de Sevilla; Tomas Alvaro; Mercedes Garcia Villanueva; Vicens Romagosa; Silvia de Sanjose
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 9.  Intravesical treatments of bladder cancer: review.

Authors:  Zancong Shen; Tong Shen; M Guillaume Wientjes; Michael A O'Donnell; Jessie L-S Au
Journal:  Pharm Res       Date:  2008-03-28       Impact factor: 4.200

10.  Penetration kinetics of 2',3'-dideoxyinosine in dermis is described by the distributed model.

Authors:  E Gupta; M G Wientjes; J L Au
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.